Affin earns spot on Fortune Southeast Asia 500 list again

KUALA LUMPUR: Affin Group has been named one of Southeast Asia's largest companies by Fortune for the second consecutive year, recognised for its revenue, profit, balance sheet strength, and employee base.
Affin Group said in a statement that this achievement strengthens its strategic presence in the region's evolving financial ecosystem.
President and group chief executive officer Datuk Wan Razly Abdullah said the group's continued inclusion in the Fortune Southeast Asia 500 list reflects its growing strength and relevance in a rapidly changing financial landscape.
Wan Razly said it indicates the group is "not only keeping pace but moving ahead with focused ambition and a clear strategic agenda".
"As we commemorate 50 years of Always About You, this milestone reinforces our long-term commitment to value creation.
"Guided by the Affin Axelerate 2028 (AX28) Plan, we are advancing with purpose, strengthening client partnerships, unlocking new growth opportunities, and delivering impact where it matters most," he said.
Further demonstrating its strong growth, Affin Group recently secured its first international credit rating of A3 with a stable outlook from Moody's Investors Service.
The group also successfully debuted in the US dollar bond market, attracting strong global investor demand. The final order book exceeded US$1 billion across 67 investor accounts, representing a 3.5 times oversubscription.
These achievements reflect strong investor confidence and affirm Affin's growing credibility in both regional and international markets.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Malaysian Reserve

a day ago

• Malaysian Reserve

Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in North Las Vegas

BIRMINGHAM, Ala. and LAS VEGAS, June 18, 2025 /PRNewswire/ — Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in North Las Vegas, Nevada. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians. The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, in-house dialysis suite, dining room, pharmacy and therapy courtyard. 'We are excited to begin construction and progress toward opening another hospital in the Las Vegas market,' said Kim Steward, president of Encompass Health's West region. 'The hospital will provide residents in the North Las Vegas community access to high-quality, compassionate rehabilitative care close to their homes.' The hospital, expected to open by 2028, will be part of Encompass Health's national network of inpatient rehabilitation hospitals and its 4th location in Nevada. About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 168 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare and Forbes' Most Trusted Companies in America. For more information, visit or follow us on our newsroom, X, Instagram and Facebook. From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. Forward-Looking StatementsStatements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2024 and 10-Q for the quarter ended March 31, 2025. Media contact:Polly Manuel | 205-970-5912media@ Investor Relations contact:Mark Miller |

Borneo Post

2 days ago

• Borneo Post

OM Holdings secures spot on Fortune Southeast Asia 500 list for second year

The company's flagship smelting facility in Sarawak remains one of the largest and most cost-efficient in the region outside China, supporting its competitive edge. KUALA LUMPUR (June 19): OM Holdings Limited (OMH), an international manganese and silicon smelting group, has once again made it onto the Fortune Southeast Asia 500 list, ranking 378th this year. This marks the second consecutive year the company has been included in the prestigious list, which recognises the top-performing companies in the region based on annual revenue. 'The company's continued inclusion on the Fortune Southeast Asia 500 list is a strong validation of its scale, resilience and sustained operating and financial performance, amid a period of elevated market volatility since 2024,' it said in a statement on Tuesday. OMH executive chairman and CEO Low Ngee Tong said the recognition affirms the consistency of the company's strategy and operational discipline, particularly during a year where the ferroalloy markets experienced significant pricing swings and cost pressures. 'In 2024, we operated in an environment marked by sharp manganese alloy price movements, regulatory shifts in China impacting ferrosilicon trade, and broader macroeconomic headwinds. Through it all, our team remained focused on cost control, procurement discipline, and production optimisation. 'These efforts enabled us to deliver record production volumes, remain profitable, and continue creating long-term shareholder value,' he said. For the financial year ended Dec 31, 2024, the group recorded revenue of US$654.3 million, an increase of 11 per cent from the previous year. It sold over 500,000 tonnes of ferrosilicon and silicomanganese. Earnings before interest, tax, depreciation and amortisation (EBITDA) came in at US$76.0 million, with net profit after tax at US$9.7 million. OMH also declared a final dividend of A$0.004 per share. The company's flagship smelting facility in Sarawak remains one of the largest and most cost-efficient in the region outside China, supporting its competitive edge. OMH also maintains a trading and marketing presence in Singapore, Japan, and China, and owns a manganese asset in Australia targeted for ultra-fines processing. The Fortune Southeast Asia 500 list, launched in June 2024, highlights the region's top companies based on revenue. corporate news Fortune Southeast Asia 500 OM Holdings Limited

The Star

2 days ago

• The Star

13MP to be tabled in Parliament on July 28

PUTRAJAYA: The 13th Malaysia Plan (13MP) is expected to be tabled in Parliament on July 28, says government spokesman Datuk Fahmi Fadzil. He said at the Cabinet meeting yesterday, Economy Ministry secretary-general Datuk Nor Azmie Diron presented a briefing summary on the Plan's implementation. Fahmi said Prime Minister Datuk Seri Anwar Ibrahim had requested all ministries to review the draft presented and provide feedback to the ministry before it is finalised for tabling in Parliament. 'This will be the first Malaysia Plan to be tabled by the Prime Minister,' he said at his weekly press conference yesterday. On Tuesday, Anwar had said that the Plan would mark a turning point in the government's efforts to address national economic challenges, including development and income gaps, limited fiscal space, and the slow pace of structural economic transition. The 13MP, which covers 2026-2030 is one of the government's key policy documents for implementing its economic agenda. On another matter, Fahmi said enforcement measures to curb the online sale of prohibited items, including drug-laced vape products, will soon be laid out. He said a meeting will be held with Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali and Health Minister Datuk Seri Dr Dzulkefly Ahmad to discuss enforcement measures on banned products. This includes the sale of liquids believed to contain banned drugs through apps, social media platforms and online in general. Fahmi said the move reflects the government's commitment to tackling the widespread availability of such products online. 'The outcome of the meeting will be presented to the Cabinet, followed by enforcement action against individual sellers or platforms that enable such sales.' Fahmi also said the Online Safety Act 2024 is expected to be enforced soon after several key processes related to the legislation are finalised, adding he is currently awaiting the draft of the Act. 'Once it is ready and I sign the gazette to enforce the Act, it will come into effect,' he said. Fahmi said a committee will also be set up by the Minister in the Prime Minister's Department (Law and Institutional Reform), Datuk Seri Azalina Othman Said, to oversee the implementation of the Act. 'This committee will have regulatory powers over the enforcement of the Act, such as defining what constitutes online harms,' he explained.